Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 74

Sort by

Sort Order Select

Journal Articles

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Blood (2025) 146 (Supplement 1): 5806.

https://doi.org/10.1182/blood-2025-5806

Published: 2025

Journal Articles

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Eric J. Zhao, Sujaatha Narayanan, Florian Kuchenbauer, Stephen Nantel, Thomas Nevill, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Hannah Cherniawsky, Judith Rodrigo, Kevin Song, Cynthia Toze, Jennifer White, Claudie Roy, Aly Karsan, Ryan Stubbins, David Sanford

Blood (2025) 146 (Supplement 1): 5178.

https://doi.org/10.1182/blood-2025-5178

Published: 2025

Journal Articles

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Blood (2025) 146 (Supplement 1): 2815.

https://doi.org/10.1182/blood-2025-2815

Published: 2025

Journal Articles

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Bo Wan, Curtis Hughesman, Yasser Abou Mourad, Shanee Chung, Donna Forrest, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Hannah Cherniawsky, Judith Rodrigo, Aly Karsan, Sean Young, Kevin Song, Ryan Stubbins, Cynthia Toze, Jennifer White, Claudie Roy, David Sanford

Blood (2025) 146 (Supplement 1): 1738.

https://doi.org/10.1182/blood-2025-1738

Published: 2025

Journal Articles

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Blood (2025) 146 (Supplement 1): 6212.

https://doi.org/10.1182/blood-2025-6212

Published: 2025

Journal Articles

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Nicholas Chornenki, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen Nantel, Sujaatha Narayanan, Thomas Nevill, Judith Rodrigo, Claudie Roy, Kevin Song, Cynthia Toze, Jennifer White, David Sanford, Ryan Stubbins

Blood (2025) 146 (Supplement 1): 5222.

https://doi.org/10.1182/blood-2025-5222

Published: 2025

Journal Articles

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Amani Ahmed, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7417.

https://doi.org/10.1182/blood-2024-206077

Published: 2024

Journal Articles

Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma

Marios Papadimitriou, Marilena Tauro, Afsaneh Panahi, Bachisio Ziccheddu, Alexandra Maria Poos, Abdessamad Youssfi Alaoui, Dario Magaletti, Mark B. Meads, Kylee H Maclachlan, Marc S. Raab, Gareth Morgan, Saad Z. Usmani, Niels Weinhold, Ola Landgren, Kenneth H. Shain, Florian Kuchenbauer, Francesco Maura

Blood (2024) 144 (Supplement 1): 3276.

https://doi.org/10.1182/blood-2024-211173

Published: 2024

Journal Articles

Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1 :: RUNX1T1

Blood (2024) 144 (Supplement 1): 2954.

https://doi.org/10.1182/blood-2024-199996

Published: 2024

Journal Articles

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

Satarupa Mohapatra, Yasser Abou Mourad, Hannah Cherniawsky, Shanee Chung, Donna L. Forrest, Gagan Kalia, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Deepesh Lad

Blood (2024) 144 (Supplement 1): 7910.

https://doi.org/10.1182/blood-2024-206266

Published: 2024

Journal Articles

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Blood (2024) 144 (Supplement 1): 7649.

https://doi.org/10.1182/blood-2024-193967

Published: 2024

Journal Articles

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Neelan Sriranjan, Shanee Chung, Hannah Cherniawsky, Donna L. Forrest, Deepesh Lad, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Yasser Abou Mourad

Blood (2024) 144 (Supplement 1): 7113.

https://doi.org/10.1182/blood-2024-211092

Published: 2024

Journal Articles

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Blood (2024) 144 (Supplement 1): 2919.

https://doi.org/10.1182/blood-2024-209687

Published: 2024

Journal Articles

Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial

Blood (2024) 144 (Supplement 1): 733.

https://doi.org/10.1182/blood-2024-209097

Published: 2024

Journal Articles

Preclinical In Vivo Imaging of Multiple Myeloma with [ 18 f]Fluorohomoleucine (FHL) PET/CT

Milena Colovic, Matthew Nodwell, Leo Escano, Nadine Colpo, Ingrid Bloise, Gokce Engudar, Helen Merkens, Francois Benard, Paul Schaffer, Florian Kuchenbauer, Robert Britton

Blood (2023) 142 (Supplement 1): 1935.

https://doi.org/10.1182/blood-2023-188363

Published: 2023

Journal Articles

Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada

Bo Wan, Yasser Abou Mourad, Shanee Chung, Donna L. Forrest, Florian Kuchenbauer, Stephen H. Nantel, Sujaatha Narayanan, Thomas J. Nevill, Maryse Power, Judith Anula Rodrigo, David Sanford, Kevin Song, Ryan J Stubbins, Heather J. Sutherland, Cynthia L. Toze, Jennifer White, Claudie Roy, Kevin A Hay

Blood (2023) 142 (Supplement 1): 3559.

https://doi.org/10.1182/blood-2023-185055

Published: 2023

Journal Articles

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Shanee Chung, Ashley Kate McEwan, Yasser Abou Mourad, Donna L. Forrest, Kevin Hay, Florian Kuchenbauer, Stephen H. Nantel, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, David Sanford, Kevin Song, Ryan J Stubbins, Cynthia L. Toze, Jennifer White, Sujaatha Narayanan

Blood (2023) 142 (Supplement 1): 6972.

https://doi.org/10.1182/blood-2023-190446

Published: 2023

Journal Articles

Wilms' Tumor 1 Functions As a Tumor Suppressor to Suppress FLT3-STAT Signaling and Epigenetic Remodeling in Acute Myeloid Leukemia (CALGB 8461, 9665 and 20202; Alliance)

Blood (2023) 142 (Supplement 1): 4126.

https://doi.org/10.1182/blood-2023-188892

Published: 2023

Journal Articles

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

Shouriyo Ghosh, Florian Kuchenbauer, Ryan J Stubbins, Shanee Chung, Sujaatha Narayanan, Thomas J. Nevill, Kevin Song, Judith Anula Rodrigo, Jennifer White, Claudie Roy, Yasser Abou Mourad, Stephen H. Nantel, Donna L. Forrest, Cynthia L. Toze, Kevin A Hay, Maryse Power, David Sanford

Blood (2023) 142 (Supplement 1): 1482.

https://doi.org/10.1182/blood-2023-182466

Published: 2023

Journal Articles

Targeting the WT1 mut -M ir-193a Transcriptional Axis with INT-1B3, a Novel Lipid Nanoparticle-Formulated Mir -193a-3p Mimic in Acute Myeloid Leukemia

Blood (2022) 140 (Supplement 1): 6224–6225.

https://doi.org/10.1182/blood-2022-157833

Published: 2022

Update search

NARROW

Publications

Format

Subjects

Article Type

Topics

Date

Availability

Incidence and characteristics of infections in patients with multiple myeloma treated with BCMA bispecific antibodies in British Columbia

Performance of the ELN 2022 risk stratification in a real-world Canadian AML patient population

Who participates in myeloma trials? clinical and geographic predictors of access and outcomes in British Columbia, Canada.

Outcomes following MRD relapse in AML patients monitored by droplet digital PCR

Upfront comprehensive donor search overcomes the impact of poor search prognosis, irrespective of racial background

Survival outcomes with the use of gemtuzumab-ozogamycin in patients with acute myeloid leukemia receiving intensive chemotherapy stratified by molecular risk category

Excellent Outcome of Myeloablative TBI-Based Allogeneic Stem Cell Transplant in Adult Patients with Acute Lymphocytic Leukemia in MRD Negative CR1: Results from a Retrospective Canadian Cohort

Replication Stress Induces Hyper-Apobec Mutagenesis in Multiple Myeloma

Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1 :: RUNX1T1

Racial Disparity in Outcomes after Myeloablative Conditioning for Hematological Malignancies in Patients Above the Age of 45 Years Undergoing Hematopoietic Stem Cell Transplantation

CMV Reactivation Pre and Post Letermovir Prophylaxis, a Single Centre Review of Clinical Outcomes and Resource Utilization

Routine Prophylactic Granulocyte Colony-Stimulating Factor Use Post Autologous Peripheral Blood Stem Cell Transplantation for Hodgkin's Disease, Non-Hodgkin's Lymphoma and Germ Cell Tumors Shortens Duration of Hospital Stay and Reduces Mortality: A Retrospective Single Center Experience

Survival Outcomes for Patients with Acute Myeloid Leukemia with Myelodysplasia Related Changes (AML-MRC) in a Real-World, Retrospective Cohort Receiving Intensive Chemotherapy

Efficacy and Safety of Uproleselan Combined with Chemotherapy Vs. Chemotherapy Alone in Relapsed/Refractory Acute Myeloid Leukemia: Findings from an International Phase 3 Trial

Preclinical In Vivo Imaging of Multiple Myeloma with [ 18 f]Fluorohomoleucine (FHL) PET/CT

Real-World Outcomes of Pfts in Screening for Lung Involvement in Chronic Gvhd Post-Allogeneic Stem Cell Transplant: A Retrospective Study of 387 Patients in British Columbia, Canada

British Columbia Experience in Allogeneic Stem Cell Transplantation for Myelofibrosis with or without Pre-Transplant Ruxolitinib

Wilms' Tumor 1 Functions As a Tumor Suppressor to Suppress FLT3-STAT Signaling and Epigenetic Remodeling in Acute Myeloid Leukemia (CALGB 8461, 9665 and 20202; Alliance)

Improvement in Survival of Patients with FLT3 Mutated Acute Myeloid Leukemia: Results from a Retrospective Canadian Cohort

Targeting the WT1 mut -M ir-193a Transcriptional Axis with INT-1B3, a Novel Lipid Nanoparticle-Formulated Mir -193a-3p Mimic in Acute Myeloid Leukemia

Email alerts

ASH Publications

American Society of Hematology

Update search

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only